Research and Development (R&D) expenses: R&D expenses were $22.9 million for the first quarter of 2025, compared to $33.7 million for the first quarter of 2024. General and Administrative (G&A) ...

The FDA approved ustekinumab-aekn (Selarsdi) injection as an interchangeable biosimilar to Stelara for the treatment of Crohn ...

Dating with Crohn's? Here are five proven tips to have a successful dating life, no matter what Crohn’s decides to ...

Mark Wright, 38, has opened up on the 'brutal' IVF journey he and his wife went through as he aims to raise awareness of ...

The Global Burden of Disease study highlights the rising cases of Inflammatory Bowel Disease in India, emphasizing the need ...

Crohn’s Disease and Ulcerative Colitis affects more than a million people including their families in Southern California ...

In biologic-naive patients with CD, there were no differences in clinical remission or disease progression between those who ...

One of the best ways to maximize absorption is through proper gut health. Before trying vitamin supplements, it's important ...

Agomab Therapeutics NV (“Agomab”) today announced late-breaking interim data from the ongoing STENOVA1 Phase 2a clinical trial for AGMB-129, an oral gastro-intestinal (GI)-restricted small molecule ...

I’m always looking for snacks that you can take with you,” says Julie Cepo, RD, a coauthor of the Crohn’s & Colitis Diet ...

Stroke and coronary artery disease were the primary causes linked to the deaths of all participants with autoimmune disease, ...

Selarsdi, a biosimilar to Stelara, is approved for adult and pediatric psoriatic arthritis, plaque psoriasis, Crohn disease, ...